Search

Search Constraints

You searched for: Author/Creator Zou, Yutian

Search Results

4. Development and validation of a stromal immune phenotype classifier for predicting immune activity and prognosis in triple‐negative breast cancer. Issue 2 (30th April 2020)

5. Dissecting the role of cancer‐associated fibroblast‐derived biglycan as a potential therapeutic target in immunotherapy resistance: A tumor bulk and single‐cell transcriptomic study. Issue 2 (11th February 2023)

9. Landscape of cancer-associated fibroblasts identifies the secreted biglycan as a protumor and immunosuppressive factor in triple-negative breast cancer. (31st December 2022)